143 related articles for article (PubMed ID: 37355441)
21. A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis.
Rombout-Sestrienkova E; Winkens B; van Kraaij M; van Deursen CTBM; Janssen MCH; Rennings AMJ; Evers D; Kerkhoffs JL; Masclee A; Koek GH
J Clin Apher; 2021 Jun; 36(3):340-347. PubMed ID: 33368569
[TBL] [Abstract][Full Text] [Related]
22. Current applications of therapeutic phlebotomy.
Assi TB; Baz E
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s75-83. PubMed ID: 24120605
[No Abstract] [Full Text] [Related]
23. Advantages of isovolemic large-volume erythrocytapheresis as a rapidly effective and long-lasting treatment modality for red blood cell depletion in patients with polycythemia vera.
Kaboth U; Rumpf KW; Liersch T; Vehmeyer K; Krieter D; Kaboth W
Ther Apher; 1997 May; 1(2):131-4. PubMed ID: 10225758
[TBL] [Abstract][Full Text] [Related]
24. [Erythrocytapheresis for hereditary haemochromatosis].
Rombout-Sestrienkova E; van Deursen CT; Janssen MC; van Kraaij MG; de Leeuw PW; Koek GH
Ned Tijdschr Geneeskd; 2012; 156(26):A4745. PubMed ID: 22759710
[TBL] [Abstract][Full Text] [Related]
25. The Italian registry of therapeutic apheresis enters the information system of transfusion services - SISTRA.
de Silvestro G; Catalano L; Marano G; Piccinini V; Pupella S; Ostuni A; de Angelis V
Transfus Apher Sci; 2022 Feb; 61(1):103287. PubMed ID: 34627712
[TBL] [Abstract][Full Text] [Related]
26. Italian Registry of Therapeutic Apheresis.
De Silvestro G; Tison T;
Transfus Apher Sci; 2018 Apr; 57(2):143-147. PubMed ID: 29703557
[TBL] [Abstract][Full Text] [Related]
27. [Erythrocytapheresis in the complex treatment of polycythemia vera].
Kovaleva LG; Melikian AL; Kho PI; Sedova GT; Petrov MM
Gematol Transfuziol; 1987 Nov; 32(11):10-4. PubMed ID: 3428540
[No Abstract] [Full Text] [Related]
28. Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresis.
Kaboth U; Rumpf KW; Lipp T; Bigge J; Nauck M; Beyer JH; Seyde W; Kaboth W
Klin Wochenschr; 1990 Jan; 68(1):18-25. PubMed ID: 2308267
[TBL] [Abstract][Full Text] [Related]
29. Automated red blood cell depletion: Results from a validation trial of the Fenwal Amicus new red blood cell depletion program.
Sanderson F; Cauchois R; Berda-Haddad Y; Poullin P
J Clin Apher; 2020 Aug; 35(4):335-341. PubMed ID: 32619335
[TBL] [Abstract][Full Text] [Related]
30. The role of erythrocytapheresis in secondary erythrocytosis therapy.
Bláha M; Skorepová M; Masín V; Spásová I; Paráková Z; Malý J; Zák P; Belada D; Turková A
Clin Hemorheol Microcirc; 2002; 26(4):273-5. PubMed ID: 12122233
[No Abstract] [Full Text] [Related]
31. Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study.
Rombout-Sestrienkova E; van Noord PA; van Deursen CT; Sybesma BJ; Nillesen-Meertens AE; Koek GH
Transfus Apher Sci; 2007 Jun; 36(3):261-7. PubMed ID: 17569592
[TBL] [Abstract][Full Text] [Related]
32. How do I…perform therapeutic phlebotomy?
Peedin AR; Karp JK
Transfusion; 2021 Mar; 61(3):673-677. PubMed ID: 33580971
[TBL] [Abstract][Full Text] [Related]
33. The Italian registry of therapeutic apheresis: year of activity 2021.
de Silvestro G; Catalano L; Marano G; Piccinini V; Cannata L; Ostuni A; de Angelis V
Transfus Apher Sci; 2023 Jun; 62(3):103652. PubMed ID: 36804188
[TBL] [Abstract][Full Text] [Related]
34. Erythrocytapheresis with recombinant human erythropoietin in hereditary hemochromatosis therapy: a new alternative.
Kohan A; Niborski R; Daruich J; Rey J; Bastos F; Amerise G; Herrera R; García M; Olivera W; Santarelli MT; Avalos JS; Findor J
Vox Sang; 2000; 79(1):40-5. PubMed ID: 10971213
[TBL] [Abstract][Full Text] [Related]
35. Erythrocytapheresis. A method for rapid extracorporeal elimination of erythrocytes. Results in 65 patients.
Zoller WG; Kellner H; Spengel FA
Klin Wochenschr; 1988 May; 66(9):404-9. PubMed ID: 3392895
[TBL] [Abstract][Full Text] [Related]
36. Interventions for hereditary haemochromatosis: an attempted network meta-analysis.
Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011647. PubMed ID: 28273330
[TBL] [Abstract][Full Text] [Related]
37. [Effect of erythrocytapheresis on the oxygen-transport function of the blood in patients with polycythemia vera].
Vinogradova IL; Bagriantseva SIu; Melikian AL; Kovaleva LG; Skachilova NN
Gematol Transfuziol; 1986 Jan; 31(1):42-4. PubMed ID: 3956970
[No Abstract] [Full Text] [Related]
38. The Italian SIdEM registry for apheresis: an overview of the 2005 statistics.
De Silvestro G; Bagatella P; Vicarioto M; Tison T; Marson P
Int J Artif Organs; 2008 Apr; 31(4):354-62. PubMed ID: 18432593
[TBL] [Abstract][Full Text] [Related]
39. How to manage polycythemia vera.
Passamonti F
Leukemia; 2012 May; 26(5):870-4. PubMed ID: 22157736
[TBL] [Abstract][Full Text] [Related]
40. The role of erythrocytapheresis in secondary erythrocytosis therapy.
Pollari G; Antonini V; Izzo A; Moreschini G; Serraino M; Tonelli V; D'Angiolino A; Migliaccio M
Clin Hemorheol Microcirc; 1999; 21(3-4):353-5. PubMed ID: 10711770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
